
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19
Yuying Liu, Jiadi Lv, Jiangning Liu, et al.
Cell Research (2020) Vol. 30, Iss. 12, pp. 1078-1087
Open Access | Times Cited: 117
Yuying Liu, Jiadi Lv, Jiangning Liu, et al.
Cell Research (2020) Vol. 30, Iss. 12, pp. 1078-1087
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 157
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 157
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
Jiadi Lv, Zhenfeng Wang, Yajin Qu, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 139
Jiadi Lv, Zhenfeng Wang, Yajin Qu, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 139
Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Natalie C. Sondermann, Sonja Faßbender, Frederick Hartung, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115371-115371
Open Access | Times Cited: 74
Natalie C. Sondermann, Sonja Faßbender, Frederick Hartung, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115371-115371
Open Access | Times Cited: 74
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
AHR signaling is induced by infection with coronaviruses
Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
Federico Giovannoni, Zhaorong Li, Federico Remes-Lenicov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
Takafumi Kato, Takanori Asakura, Caitlin E. Edwards, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 11, pp. 1336-1352
Open Access | Times Cited: 53
Takafumi Kato, Takanori Asakura, Caitlin E. Edwards, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 11, pp. 1336-1352
Open Access | Times Cited: 53
Lung targeted liposomes for treating ARDS
Sivan Arber Raviv, Mohammed Alyan, Е.В. Егоров, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 421-433
Open Access | Times Cited: 52
Sivan Arber Raviv, Mohammed Alyan, Е.В. Егоров, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 421-433
Open Access | Times Cited: 52
Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
Jiandong Shi, Tingfu Du, Junbin Wang, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 29
Jiandong Shi, Tingfu Du, Junbin Wang, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 29
Metabolic Reprogramming in COVID-19
Tao Shen, Tingting Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11475-11475
Open Access | Times Cited: 49
Tao Shen, Tingting Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11475-11475
Open Access | Times Cited: 49
CD38 in the age of COVID-19: a medical perspective
Alberto L. Horenstein, Angelo Corso Faini, Fabio Malavasi
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1457-1486
Open Access | Times Cited: 47
Alberto L. Horenstein, Angelo Corso Faini, Fabio Malavasi
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1457-1486
Open Access | Times Cited: 47
The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity
María F. Torti, Federico Giovannoni, Francisco J. Quintana, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
María F. Torti, Federico Giovannoni, Francisco J. Quintana, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence
Nuno R. Coelho, António B. Pimpão, Maria João Correia, et al.
Journal of Molecular Medicine (2021) Vol. 100, Iss. 2, pp. 215-243
Open Access | Times Cited: 43
Nuno R. Coelho, António B. Pimpão, Maria João Correia, et al.
Journal of Molecular Medicine (2021) Vol. 100, Iss. 2, pp. 215-243
Open Access | Times Cited: 43
Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligands
Zdeněk Dvořák, Karolína Poulíková, Sridhar Mani
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113231-113231
Closed Access | Times Cited: 42
Zdeněk Dvořák, Karolína Poulíková, Sridhar Mani
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113231-113231
Closed Access | Times Cited: 42
LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs
Rongmu Xia, Guojun Geng, Xiuyi Yu, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002746-e002746
Open Access | Times Cited: 42
Rongmu Xia, Guojun Geng, Xiuyi Yu, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002746-e002746
Open Access | Times Cited: 42
Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Zhenfeng Wang, Shunshun Li, Bo Huang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections
Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 30
Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 30
The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Olaf Perdijk, Rossana Azzoni, Benjamin J. Marsland
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 835-879
Closed Access | Times Cited: 21
Olaf Perdijk, Rossana Azzoni, Benjamin J. Marsland
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 835-879
Closed Access | Times Cited: 21
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 20
Abdulla A.‐B. Badawy
Bioscience Reports (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 20
Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism
Liyun Zhao, Liyuan Yao, Rui Chen, et al.
Antiviral Research (2023) Vol. 212, pp. 105570-105570
Open Access | Times Cited: 17
Liyun Zhao, Liyuan Yao, Rui Chen, et al.
Antiviral Research (2023) Vol. 212, pp. 105570-105570
Open Access | Times Cited: 17
Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
Yiheng Mao, Ying Chen, Yuan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113689-113689
Open Access | Times Cited: 8
Yiheng Mao, Ying Chen, Yuan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113689-113689
Open Access | Times Cited: 8
The role of the AHR in host–pathogen interactions
Palmira Barreira‐Silva, Yilong Lian, Stefan H. E. Kaufmann, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 7
Palmira Barreira‐Silva, Yilong Lian, Stefan H. E. Kaufmann, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 7
Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma
Xinyue Hu, Ying‐Chun Shen, Yilin Zhao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Xinyue Hu, Ying‐Chun Shen, Yilin Zhao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
Zhenfeng Wang, Jiadi Lv, Pin Yü, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 210-221
Open Access | Times Cited: 25
Zhenfeng Wang, Jiadi Lv, Pin Yü, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 210-221
Open Access | Times Cited: 25
Modeling mucus physiology and pathophysiology in human organs-on-chips
Zohreh Izadifar, Alexandra Sontheimer-Phelps, Bob Lubamba, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114542-114542
Closed Access | Times Cited: 23
Zohreh Izadifar, Alexandra Sontheimer-Phelps, Bob Lubamba, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114542-114542
Closed Access | Times Cited: 23
Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection
Qian Li, Kadambari Vijaykumar, Scott E. Phillips, et al.
JCI Insight (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Qian Li, Kadambari Vijaykumar, Scott E. Phillips, et al.
JCI Insight (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15